Shantha Biotechnics Limited
16
0
0
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
6.3%
1 terminated/withdrawn out of 16 trials
92.3%
+5.8% vs industry average
44%
7 trials in Phase 3/4
0%
0 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
PXVX0200 (CVD103-HgR) vs Shanchol in Mali
Role: collaborator
Bridging Study for Killed Oral Cholera Vaccine in Ethiopia
Role: collaborator
Safety and Immunogenicity of a Killed Oral Cholera Vaccine in Infants
Role: collaborator
Randomized Controlled Trial of Killed Oral Cholera Vaccine in Kolkata
Role: collaborator
A Study to Evaluate Safety and Immunogenicity of the Bivalent Killed Whole Cell Oral Cholera Vaccine in Adults and Children
Role: collaborator
Study of Alternative Vaccination Schedule of Oral Cholera Vaccine
Role: collaborator
Pilot Introduction of Oral Cholera Vaccine in Orissa, India
Role: collaborator
A Study to Evaluate the Safety of Tetravalent Rotavirus Vaccine in Healthy Indian Adult Male Volunteers
Role: lead
Safety and Immunogenicity Study of the Tetravalent Rotavirus Vaccine
Role: lead
Safety and Efficacy Trial of Recombinant Human Granulocyte Colony Stimulating Factor (GCSF)
Role: lead
Safety and Immunogenicity Study of the Recombinant Human Bovine Reassortant Rotavirus Vaccine in Healthy Indian Infants
Role: lead
Immunogenicity of One Versus Two Doses of Killed Oral Cholera Vaccine
Role: collaborator
Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine
Role: lead
Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine
Role: lead
Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine
Role: lead
Safety and Immunogenicity of Oral Cholera Vaccine in Kolkata
Role: collaborator
All 16 trials loaded